Keep Antibiotics Working campaign success survey launched

Keep Antibiotics Working campaign success survey launched

January 16 2018 Community pharmacists in Scotland are being asked for their views on the recent...

MHRA warns of confusion over drug names and potential for errors

MHRA warns of confusion over drug names and potential for errors

January 11 2018 Healthcare professionals are being asked to be extra vigilant when dispensing or...

Co-dydramol strengths and herbal medicines among latest Drug Safety Update advice

Co-dydramol strengths and herbal medicines among latest Drug Safety Update advice

January 10 2018 The medicines regulator has highlighted the different strengths of co-dydramol in...

Pharmacist Support announces five new trustees

Pharmacist Support announces five new trustees

January 9 2018 Five new trustees have been appointed by Pharmacist Support, the independent...

NHS England promoting new round of applications for practice pharmacists

NHS England promoting new round of applications for practice pharmacists

January 9 2018 NHS England is urging general practices to consider recruiting pharmacists to work...

  • Keep Antibiotics Working campaign success survey launched

    Keep Antibiotics Working campaign success survey launched

    Tuesday, 16 January 2018 13:25
  • MHRA warns of confusion over drug names and potential for errors

    MHRA warns of confusion over drug names and potential for errors

    Thursday, 11 January 2018 12:35
  • Co-dydramol strengths and herbal medicines among latest Drug Safety Update advice

    Co-dydramol strengths and herbal medicines among latest Drug Safety Update advice

    Wednesday, 10 January 2018 15:57
  • Pharmacist Support announces five new trustees

    Pharmacist Support announces five new trustees

    Tuesday, 09 January 2018 11:41
  • NHS England promoting new round of applications for practice pharmacists

    NHS England promoting new round of applications for practice pharmacists

    Tuesday, 09 January 2018 11:36

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a alert imageJanuary 11 2018

Healthcare professionals are being asked to be extra vigilant when dispensing or prescribing medicines with commonly confused drug names.

The MHRA’s latest Drug Safety Update gives a list of common errors of names that sound alike or look alike:

clobazam (benzodiazepine)

clonazepam (antiepileptic drug)

atenolol (beta blocker)

amlodipine (calcium channel blocker)

propranolol (beta blocker)

prednisolone (corticosteroid)

risperidone (antipsychotic)

ropinirole (dopamine agonist)

sulfadiazine (antibiotic)

sulfasalazine (disease-modifying anti-rheumatic drug)

amlodipine (indicated for hypertension and angina)         

nimodipine (indicated for the prevention of ischaemic neurological deficits following aneurysmal subarachnoid haemorrhage)

“We are aware of recent cases, including cases with fatal outcomes, in which patients have received the wrong medicine due to confusion between similarly named or sounding brand or generic names,” said the MHRA. “Since our last Drug Safety Update on drug-name confusion in 2013, we have received Yellow Card reports of harm following confusion between the drugs listed in the table.”

The MHRA says “if pharmacists have any doubt about which medicine is intended, contact the prescriber before dispensing the drug.” They should also “follow local and professional guidance in relation to checking the right medicine has been dispensed to a patient.”

Health professionals are asked to “report suspected adverse drug reactions where harm has occurred as a result of a medication error on a Yellow Card or via local risk management systems that feed into the National Reporting and Learning System.”

Links:
MHRA Drug Safety Update: monthly PDF newsletters        
MHRA Drug Safety Update: monthly PDF newsletter. January 6 2018. 11;6.                 
Drug name confusion DSU – January 2018              
Drug name confusion DSU – April 2013  

Practice News

January 18 2018 Pharmacists are being urged to express their views on the impact of UK-wide proposals to reschedule pregabalin and gabapentin as controlled drugs.
January 18 2018 Delays in releasing funding promised to support community pharmacy’s role in integrated care is contributing to the current hospital pressures, Sandra Gidley has warned.